Recent Finacing
Recent Raise
SiteOne Therapeutics develops selective small-molecule NaV1.7/NaV1.8 inhibitors and diagnostic imaging agents targeting peripheral sensory neurons to treat chronic pain, chronic cough, and ocular surface pain.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at SiteOne Therapeutics.
